Search for
Menu
About
+
Overview
Impact
Partners
Team
Entrepreneurs
+
Work with Us
Industries
Internship Program
Innovation Center
Mentors
Corporates
Capital
+
Rev1 Capital
Funds
Portfolio
Resources
+
Startup Resources
Blog
Entrepreneur Toolkit
Jobs
Events
Get Started
About
+
Overview
Impact
Partners
Team
Entrepreneurs
+
Work with Us
Industries
Internship Program
Innovation Center
Mentors
Corporates
Capital
+
Rev1 Capital
Funds
Portfolio
Resources
+
Startup Resources
Blog
Entrepreneur Toolkit
Jobs
Events
Get Started
Search for
Search Results
Search results for “clarametyx“
Clarametyx Biosciences Achieves Milestones in Investment, Clinical Trials, and Industry Recognition
Getting Funding, Press, Startup Buzz
By Ashley Baig
on
12/04/2024
Getting Funding, Press, Startup Buzz
Clarametyx Biosciences Achieves Milestones in Investment, Clinical Trials, and Industry Recognition
By Ashley Baig
on
12/04/2024
Clarametyx Biosciences Announces FDA Grant Of Fast Track And Qualified Infectious Disease Product Designations For CMTX-101
Company News
08/04/2025
Clarametyx Biosciences Announces FDA Grant Of Fast Track And Qualified Infectious Disease Product Designations For CMTX-101
Clarametyx Biosciences Awarded a Multi-Phased Agreement With CARB-X to Accelerate Anti-Biofilm Vaccine to Prevent Bacterial Infections
Company News
01/07/2025
Clarametyx Biosciences Awarded a Multi-Phased Agreement With CARB-X to Accelerate Anti-Biofilm Vaccine to Prevent Bacterial Infections
Clarametyx Biosciences Announces Positive Interim Analysis in Phase 2a Study Evaluating CMTX-101 for Infections Associated with Cystic Fibrosis
Company News
06/16/2025
Clarametyx Biosciences Announces Positive Interim Analysis in Phase 2a Study Evaluating CMTX-101 for Infections Associated with Cystic Fibrosis
CincyTech Invests in Clarametyx to Advance Breakthrough Anti-Biofilm Therapies for Chronic Respiratory Disease
Company News, Funding News
05/01/2025
CincyTech Invests in Clarametyx to Advance Breakthrough Anti-Biofilm Therapies for Chronic Respiratory Disease
Clarametyx Biosciences Launches with an Ambitious Strategy to Address Life-threatening Bacterial Infections
Company News
05/04/2020
Clarametyx Biosciences Launches with an Ambitious Strategy to Address Life-threatening Bacterial Infections
Clarametyx Bioscience Recognized as “Infectious Disease Innovation of the Year” In 2024 BioTech Breakthrough Awards
Company News
11/19/2024
Clarametyx Bioscience Recognized as “Infectious Disease Innovation of the Year” In 2024 BioTech Breakthrough Awards
Clarametyx Biosciences Initiates Phase 2a Trial for CMTX-101 in Cystic Fibrosis Patients
Company News
10/24/2024
Clarametyx Biosciences Initiates Phase 2a Trial for CMTX-101 in Cystic Fibrosis Patients
Clarametyx Biosciences Announces $33M Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections
Funding News
01/05/2024
Clarametyx Biosciences Announces $33M Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections
1
2
Next »
